Impact of age on efficacy and safety of daratumumab in combination with lenalidomide and dexamethasone (D-Rd) in patients (pts) with transplant-ineligible newly diagnosed multiple myeloma (NDMM): MAIA.

Saad Zafar Usmani, Thierry Facon, Shaji Kumar, Torben Plesner, Philippe Moreau, Supratik Basu, Hareth Nahi, Margaret Macro, Hang Quach, Aurore Perrot, Chris Venner, Katja Weisel, Noopur S Raje, Michel Attal, Xavier Leleu, Maria Krevvata, Jianping Wang, Rachel Kobos, Cyrille Hulin